People in the News

Jan 18, 2018

Louis Yuan

WuXi NextCode has appointed Louis Yuan as China general manager. Yuan will be responsible for leading the firm's China businesses, sales, and other operations from its Shanghai site. Yuan joins WuXi NextCode from Becton Dickinson, where he served for the last six years as senior business unit director for its pharmaceutical systems franchise across China. Previously, he was senior director of sales at Pfizer's vaccine business in China. He has also held marketing and sales positions within Sanofi Pasteur and served as a research assistant of the Beijing AIDS Clinical Research Center at Ditan Hospital.

Jan 17, 2018

Howard Jacob

Howard Jacob has joined AbbVie as vice president of the genomic research center, leaving the HudsonAlpha Institute of Biotechnology. He had served as vice president of medical genomics and chief medical officer there since 2015. Jacob also cofounded Envision Genomics, a spinout of HudsonAlpha that aimed to make whole-genome sequencing standard of care for rare disease diagnostics. Prior to joining HudsonAlpha, Jacob served for nearly 20 years at the Medical College of Wisconsin, including as founding director of the Human and Molecular Genetics Center and as a professor of physiology. Previous to that, he was on the faculty at Massachusetts General Hospital and Harvard Medical School.

Jan 16, 2018

Michael Phillips

Michael Phillips has been named chief scientific officer of Sequence Bio, a startup biotechnology company serving the Canadian province of Newfoundland and Labrador. Phillips, who most recently was vice president of genomics at Genomics Medicine Ireland, will lead data-driven genomic and precision medicine research for Sequence Bio. The company said he would concentrate on "deep and complete multi-omic and longitudinal health information in disease-specific cohorts," including the NL Genome Project, a proposed province-wide sequencing effort.

Jan 16, 2018

Avi Pelossof

Avi Pelossof has been appointed president and CEO of Immucor, effective immediatley. Pelossof succeds CEO Jeffrey Binder, who will remain chairman of Immucor's board of directors. Pelossof joins Immucor from Alere, now part of Abbott, where he served as global president for infectious disease. With over 20 years of experience in the diagnostic space, Pelossof has also held positions at Chembio Diagnostic Systems and Citibank. 

Jan 16, 2018

Philip Beer

OncoDNA has appointed Philip Beer as its medical director in the United Kingdom. In the new position, Beer will review all of OncoDNA's reports and analyses, contacting ordering oncologists to discuss the reports with them. Aside from his new role at OncoDNA, Beer's work includes serving as a molecular and cellular pathologist at a flagship NHS diagnostic unit. He trained as a hematologist at Imperial College, London, and has pursued academic research at the University of Cambridge and the BC Cancer Agency, Vancouver. 

Jan 16, 2018

Thomas Bailey

NanoString Technologies has appointed Thomas Bailey as chief financial officer. Bailey boasts more than 20 years of experience in life sciences and healthcare organizations. Prior to joining NanoString he served as CFO at AgaMatrix Holdings, a developer, manufacturer, and marketer of medical technologies for diabetes care. Bailey was also CFO and then a CEO at Angiotech Pharmaceuticals. Bailey also has over a decade of experience in investment banking and private equity, including at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette. He holds a BA in economics from Harvard University and and MBA from Harvard Business School.

Jan 15, 2018

Dawn Berry

Dawn Berry has become president of Luna DNA, a genomic and medical research database powered by the blockchain and owned by its community. Previously, she was vice president of applied genomics at Illumina, which she joined in 2005 as a market development specialist. Prior to that, she was with Genaissance Pharmaceuticals, promoting clinical genetics testing services for pharmaceutical trials. Berry holds a BS in biology from the University of Vermont and an MBA from the University of Connecticut School of Business.

Jan 15, 2018

Linh Le

Linh Le has been appointed as chief operating officer of Ambry Genetics, which became part of Konica Minolta in October 2017. Most recently, he oversaw financial operations at Medtronic's Diabetes Intensive Insulin business unit. Prior to that, he held leadership roles at the Walt Disney Company, PricewaterhouseCoopers, Twentieth Century Fox, and KPMG.

Jan 12, 2018

Richard Olson

Life Epigenetics, the insuretech subsidiary of GWG Holdings, has named Randal Olson as its lead data scientist. He joins Life Epigenetics from the University of Pennsylvania, where he was the senior data scientist at the Computational Genetics Laboratory. Olson will lead the company's application of predictive epigenetic biomarkers to life insurance underwriting through the use of artificial intelligence and machine learning.

Jan 12, 2018

Joe Bernardo

Joe Bernardo has been named chairman of the board of SeraCare Life Sciences. Bernardo is also an operating partner at Linden Capital Partners, the equity investors behind SeraCare. Prior to these roles, he served as president of the next-generation sequencing and oncology division at Thermo Fisher Scientific. He has also worked for Siemens Healthcare, where he was senior vice president of the central lab business unit, and Abbott Laboratories.

Jan 12, 2018

Marc Malandro

Marc Malandro has been appointed to the advisory board of Helomics. Malandro is currently vice president of operations for science at the Chan Zuckerberg Initiative. He was the founding director of the Innovation Institute at the University of Pittsburgh, and vice chancellor for technology management and commercialization at the university. He also co-founded Sagres Discovery, a California-based systems biology company focused on understanding the molecular basis of cancer.

Jan 12, 2018

Daniel Pomp

Daniel Pomp has been named to the board of directors of CoreBiome, a genomics platform company focused on microbiomics research. Pomp previously founded GeneSeek, which provided DNA testing services for agribusiness and veterinary medicine and was acquired by Neogen in 2010. He is a member of the advisory board for AgriCapital, a boutique investment bank in NYC; the scientific advisory board for Locus Biosciences; and the board of directors for the Center for Entrepreneurial Development. Pomp is also a professor in the Departments of Genetics (School of Medicine) and Nutrition (School of Public Health) at the University of North Carolina-Chapel Hill.

Jan 12, 2018

Namal Nawana

Hologic elected Namal Nawana to its board of directors. Nawana was formerly the chief executive officer of Alere, which was acquired by Abbott Laboratories in Oct. 2017.  Before joining Alere, he spent 15 years at Johnson & Johnson in various leadership roles, most recently as the worldwide president of DePuy Synthes Spine.

Jan 11, 2018

Valentin Matillon

Sophia Genetics has hired Valentin Matillon as chief financial officer. Matillon, with more than 20 years of experience in senior financial management in the tech industry, takes over from Marylin Mermod Schule, who no longer will have the dual roles of CFO and chief operations officer. Matillion joins Sophia from the Hobart Group, where he had been senior director of finance. He previously worked at SITA, Electronic Arts, and Hewlett-Packard Europe, according to Switzerland-based Sophia Genetics.

Jan 09, 2018

Giulia Kennedy, Jessica Meng

Veracyte said that it is consolidating its clinical, medical, and R&D functions into one department, which will be headed by Giulia Kennedy, who has served as CSO since the company's founding in 2008. The company also appointed Jessica Meng as vice president of marketing. Meng joins Veracyte from Genentech where she led marketing for Avastin in oncology.

Jan 05, 2018

Stanley Lapidus

Stanley Lapidus has been appointed an independent board member on the board of directors of Atlas Genetics. Lapidus, who has more than three decades of experience in the medical diagnostics industry, previously founded and served as CEO of Exact Sciences, Cytyc Corp, SynapDx and Helicos Biosciences.

Jan 05, 2018

Hugh Taylor

Predictive Technology Group, a life sciences holding company specializing in genetic testing, diagnostics, and therapeutic products, has appointed Hugh Taylor to its scientific advisory board. Taylor is the Chief of Obstetrics and Gynecology at Yale University as well as a member of the National Academy of Medicine.

Jan 04, 2018

Roger Moody

Roger Moody has joined Clinical Genomics as chief financial officer. He will direct the firm's strategic and tactical financial operations. Moody had been CEO of GlySure, where he remains a director. Prior to that, he was CFO at Nanosphere; executive VP, managing director, and COO at Indegene; and CFO at Medsn before that firm was acquired by Indegene.

Jan 04, 2018

Rady Children's Institute for Genomic Medicine Scientific Advisory Board

The Rady Children's Institute for Genomic Medicine has named six individuals to its inaugural scientific advisory board. They are:

  • James Downing, president and CEO, St. Jude's Children's Research Hospital
  • Elizabeth Blackburn, president, Salk Institute for Biological Studies
  • George Church, professor, Wyss Institute at Harvard University
  • Cato Laurencin, university professor and distiguished professor, University of Connecticut
  • Thomas Insel, former director, National Institute of Mental Health at the National Institutes of Health; former director of mental health research, Verily Life Sciences; and currernt president, Mindstrong Health
  • Isaac Kohane, professor and chair of biomedical informatics, Harvard Medical School; and professor of pediatrics, Boston Children's Hospital
Jan 04, 2018

Ann Rhoads

Counsyl has appointed Ann Rhoads to its board of directors. Rhoads is former executive vice president and CFO at pharmaceutical company Zogenix. Previously, she was CFO and senior vice president at Premier. She currently serves as a board member and chair of the audit committee at Globus Medical, a musculoskeletal company, and Evoke Pharma, a pharmaceutical company that focuses on gastrointestinal disease. Rhoads Is also a board member and chair of the compensation committee at ophthalmic laser company Iridex Corporation. 

Jan 03, 2018

Michael Christman

Michael Christman, president and CEO of the Coriell Institute for Medical Research, has died. He joined Coriell in 2007 and founded the Coriell Personalized Medicine Collaborative, which studies the utility of genetics in medicine. He also co-founded pharmacogenomics company Coriell Life Sciences and served as chairman of its board of directors. Previously, he was a professor and founding chair of the Department of Genetics and Genomics at Boston University School of Medicine. Before that, he was an associate professor at the University of California, San Francisco. Christman held a doctorate in biochemistry from the University of California, Berkeley, and a bachelor's degree in chemistry from the University of North Carolina, Chapel Hill. He was also a postdoctoral fellow at the Massachusetts Institute of Technology.

Dec 27, 2017

Marcus Schabacker

Marcus Schabacker, a board-certified anesthesiologist and intensivist, has been named CEO and president of ECRI Institute, a health services research organization with an interest in genetic testing. Schabacker, who has 18 years of leadership experience in the medical device and pharmaceutical industries, recently served as chief scientific officer of Baxter. He previously helped Nelson Mandela rebuild South Africa's rural health system in the post-Apartheid era. Schabaker will replace Jeffrey Lerner, who is retiring Dec. 31 after 16 years as ECRI president and CEO.

Dec 22, 2017

Kareem Saad

Sema4 has appointed Kareem Saad as chief strategy officer. Saad was previously chief commercial officer and executive vice president of strategy and business development for Source Medical Solutions. Before that he was a director in Dell's Healthcare and Life Sciences division. He has held a number of excutive leadership roles at midsize and early-stage biotech and healthcare IT companies, and began his career by co-founding InphoGene Bionformatics.

Dec 22, 2017

Walter Nelson

KeyGene has appointed Walkter Nelson as CEO of KeyGene USA. Nelson will oversee all of KeyGene's activities in the US, Canada, and Latin America. Nelson most recently served as VP of business developnment for KeyGene. Prior to joining the company, we was VP of commercial development at Ceres.

Dec 21, 2017

Randy Scott

Invitae Chairman Randy Scott has joined the board of directors of cancer early detection firm Freenome, which also includes the company's CEO Gabriel Otte, Chief Operating Officer Riley Ennis, and Vijay Pande general partner at Andreessen Horowitz. Scott cofounded Incyte in 1991, where he served as chairman, CSO, and president. In 2000, he cofounded and led Genomic Health, and in 2012, he became CEO of Invitae before his appointment as executive chairman this year. 


Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.